Solara Active Pharma Sciences Shows Growth Amid Debt Concerns and Market Stabilization
Solara Active Pharma Sciences has experienced a recent evaluation adjustment, indicating a shift in technical trends. The company reported a 16.9% growth in net sales for the quarter ending June 2025 and a significant increase in profit before tax, despite facing challenges related to high debt levels and pledged promoter shares.
Solara Active Pharma Sciences has recently undergone an adjustment in its evaluation, reflecting a shift in its technical trends. The stock's technical indicators have shown a transition from a mildly bearish stance to a sideways movement, suggesting a stabilization in market sentiment. In terms of performance metrics, Solara Active reported a notable growth in net sales of 16.9% for the quarter ending June 2025, contributing to a very positive financial outlook. The company has consistently delivered positive results over the last four quarters, with a significant increase in profit before tax, which grew by 590.5% compared to the previous four-quarter average.
Despite these positive indicators, the company faces challenges, including a high debt-to-EBITDA ratio of 6.20 times, which raises concerns about its ability to service debt. Additionally, the proportion of pledged promoter shares has increased, which could exert downward pressure on stock prices in volatile market conditions.
Overall, while Solara Active demonstrates attractive valuation metrics and a strong recent performance, it also contends with underlying weaknesses that could impact its long-term stability.
Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
